Fresenius (OTCMKTS:FSNUY) is scheduled to be releasing its earnings data after the market closes on Tuesday, February 27th.
Shares of Fresenius (OTCMKTS FSNUY) opened at $19.67 on Monday. The company has a debt-to-equity ratio of 0.78, a quick ratio of 0.91 and a current ratio of 1.21. The stock has a market capitalization of $43,619.80, a price-to-earnings ratio of 23.41 and a beta of 0.71. Fresenius has a one year low of $17.92 and a one year high of $22.30.
Separately, UBS Group cut Fresenius from a “neutral” rating to a “sell” rating in a research note on Friday, November 17th.
ILLEGAL ACTIVITY WARNING: This story was reported by Ticker Report and is the sole property of of Ticker Report. If you are accessing this story on another publication, it was copied illegally and reposted in violation of U.S. and international trademark and copyright legislation. The original version of this story can be viewed at https://www.tickerreport.com/banking-finance/3222643/fresenius-fsnuy-scheduled-to-post-quarterly-earnings-on-tuesday.html.
Fresenius SE & Co KGaA, a health care group, provides products and services for dialysis, hospitals, and outpatient medical care worldwide. The company operates through Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed segments. The Fresenius Medical Care segment offers products for patients with chronic kidney failure.
Receive News & Ratings for Fresenius Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fresenius and related companies with MarketBeat.com's FREE daily email newsletter.